Heart Failure – Pathophysiology and Current Therapeutic Implications
AUTOR(ES)
Bello, Mariana Vieira de Oliveira; Bacal, Fernando
FONTE
Int. J. Cardiovasc. Sci.
DATA DE PUBLICAÇÃO
2020-10
RESUMO
ABSTRACT BACKGROUND: During a surgical procedure, patients are often subjected to fasting for times that are more prolonged than the ideal, which may lead to complications. OBJECTIVE: To evaluate the duration of perioperative fasting and its association with postoperative complications, length of hospital stay (LOS) and mortality among gastric and colorectal cancer patients. DESIGN AND SETTING: Cohort study developed in a surgical oncology hospital in the city of Natal (Rio Grande do Norte, Brazil). METHODS: Patients aged over 18 years were included. The Clavien-Dindo surgical complication scale was used to evaluate occurrences of postoperative complications. LOS was defined as the number of days for which patients stayed in the hospital after surgery, or until the day of death. RESULTS: Seventy-seven patients participated (59.8 ± 11.8 years; 54.5% females; 70.1% with bowel tumor). The incidences of postoperative complications and death were 59.7% and 3.9%, respectively. The duration of perioperative fasting was 59.0 ± 21.4 hours, and it was higher among non-survivors and among patients with prolonged hospital stay (≥ 6 days). For each one-hour increase in the durations of perioperative and postoperative fasting, the odds of prolonged hospitalization increased by 12% (odds ratio, OR = 1.12; 95% confidence interval, CI 1.04-1.20) and 5% (OR = 1.05; 95% CI 1.02-1.08), respectively. CONCLUSION: Prolonged perioperative fasting, especially in the postoperative period, was observed in a sample of patients with gastric and colorectal cancer, and this was an independent predictor of LOS.
Documentos Relacionados
- Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations.
- Pathophysiology of heart failure: a look at the future.
- Heart failure and atrial fibrillation: current concepts and controversies.
- Endothelin in heart failure: a promising therapeutic target?
- Vascular tone in heart failure: the neuroendocrine-therapeutic interface.